Medistim ASA (MD1) Stock Statistics & Valuation Metrics

Medistim ASA has a market cap or net worth of €373.36M. The enterprise value is €3.70K.

Medistim ASA has 18,337,336 shares outstanding. The number of shares has decreased by -2.65% in one year.

Medistim ASA’s return on equity (ROE) is 0.34 and return on invested capital (ROIC) is 28.55%.

The current PE Ratio of Medistim ASA is 26.5. Medistim ASA’s PEG ratio is ―.

In the last 12 months, Medistim ASA had revenue of 699.77M and earned 159.21M in profits. Earnings per share was 8.71.

In the last 12 months, operating cash flow was 179.97M and capital expenditures -66.01M, giving a free cash flow of 179.97M billion.

Medistim ASA pays an annual dividend of ―, resulting in a dividend yield of ―

Medistim ASA upcoming earnings date is Aug 19, 2026, TBA (Confirmed).

Medistim ASA as a current ratio of 3.34, with Debt / Equity ratio of 9.12%

In the past 12 months, Medistim ASA has paid 47.64M in taxes.

Medistim ASA EV to EBITDA ratio is 20.88, with an EV/FCF ratio of 25.17.

Medistim ASA has €209.78M in cash and marketable securities with €26.17M in debt, giving a net cash position of €163.59M billion.

Gross margin is 62.06%, with operating margin of 28.04%, and net profit margin of 22.75%.

The average price target for Medistim ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―